Genetic Background and Clinicopathologic Features Established for Adult-Onset Nephronophthisis
By LabMedica International staff writers Posted on 06 May 2021 |

Image: The Hamamatsu Photonics Nanozoomer 1 Digital Slide Scanner (Photo courtesy of University of Adelaide)
Nephronophthisis (NPH) is a genetic disorder of the kidneys which mainly affects children. It is classified as a medullary cystic kidney disease. The disorder is inherited in an autosomal recessive fashion and, although rare, is the most common genetic cause of childhood kidney failure.
Even in adult patients, accurate diagnosis of NPH is important because management options, such as kidney transplantation and appropriate genetic counseling, are available. The clinical diagnosis of adult NPH is problematic because clinical, radiologic and histologic features are non-specific. Even the extrarenal features are fewer in adults. Because management includes renal transplantation and genetic counseling, an accurate early diagnosis is essential.
Nephrologists at the Tokyo Medical and Dental University (Tokyo, Japan) investigated 18 adult patients who were suspected to have NPH by renal biopsy. The patients were recruited at 16 institutions in Japan between 2015 and 2019. For each patient, the tissue slides that were stained with hematoxylin-eosin, periodic acid-Schiff, and periodic acid–methenamine silver were digitized using the NanoZoomer HT Scan system (Hamamatsu Photonics, Hamamatsu, Japan).
Comprehensive genetic testing was performed using capture-based next-generation sequencing of 69 genes that cause nine types of hereditary cystic kidney disease, including NPH, NPH-related ciliopathies (Joubert syndrome, Meckel syndrome, Senior-Løken syndrome, Bardet-Biedl syndrome, and skeletal ciliopathies), autosomal dominant polycystic kidney disease, autosomal recessive polycystic kidney disease, and autosomal dominant tubulointerstitial kidney disease.
The scientists performed polymerase chain reaction for exons 1, 10, and 20 of NPHP1, if homozygous entire deletion of NPHP1 was detected by copy number variation analysis. To investigate what the essence of thick tubular basement membrane (TBM) duplication was, they performed low-vacuum scanning electron microscopic (Hitachi, Tokyo, Japan) analysis and immunofluorescence (IF) analysis in the representative cases with or without pathogenic mutations.
The investigators reported that seven of 18 patients had pathogenic NPH-causing mutations in NPHP1, NPHP3, NPHP4, or CEP164. Compared with patients without pathogenic mutations, those with pathogenic mutations were significantly younger, but did not significantly differ in the classic NPH pathologic findings, such as tubular cysts. On the other hand, the number of tubules with thick TBM duplication, which was defined as >10-μm thickness, was significantly higher in patients with genetically proven adult NPH than in those without pathogenic mutations. α-Smooth muscle actin (α-SMA)-positive myofibroblasts were detected inside thick TBM duplication.
The authors concluded that in adult patients with NPH, thick TBM duplication was the specific finding. Their analysis also suggested that older patients tended to have no pathogenic mutations, even when they were suspected to have NPH by renal biopsy. These findings could be the novel clinical clue for the diagnosis of NPH in adult patients. The study was published originally on March 3, 2021 in the journal Kidney International Reports.
Related Links:
Tokyo Medical and Dental University
Hamamatsu Photonics
Hitachi
Even in adult patients, accurate diagnosis of NPH is important because management options, such as kidney transplantation and appropriate genetic counseling, are available. The clinical diagnosis of adult NPH is problematic because clinical, radiologic and histologic features are non-specific. Even the extrarenal features are fewer in adults. Because management includes renal transplantation and genetic counseling, an accurate early diagnosis is essential.
Nephrologists at the Tokyo Medical and Dental University (Tokyo, Japan) investigated 18 adult patients who were suspected to have NPH by renal biopsy. The patients were recruited at 16 institutions in Japan between 2015 and 2019. For each patient, the tissue slides that were stained with hematoxylin-eosin, periodic acid-Schiff, and periodic acid–methenamine silver were digitized using the NanoZoomer HT Scan system (Hamamatsu Photonics, Hamamatsu, Japan).
Comprehensive genetic testing was performed using capture-based next-generation sequencing of 69 genes that cause nine types of hereditary cystic kidney disease, including NPH, NPH-related ciliopathies (Joubert syndrome, Meckel syndrome, Senior-Løken syndrome, Bardet-Biedl syndrome, and skeletal ciliopathies), autosomal dominant polycystic kidney disease, autosomal recessive polycystic kidney disease, and autosomal dominant tubulointerstitial kidney disease.
The scientists performed polymerase chain reaction for exons 1, 10, and 20 of NPHP1, if homozygous entire deletion of NPHP1 was detected by copy number variation analysis. To investigate what the essence of thick tubular basement membrane (TBM) duplication was, they performed low-vacuum scanning electron microscopic (Hitachi, Tokyo, Japan) analysis and immunofluorescence (IF) analysis in the representative cases with or without pathogenic mutations.
The investigators reported that seven of 18 patients had pathogenic NPH-causing mutations in NPHP1, NPHP3, NPHP4, or CEP164. Compared with patients without pathogenic mutations, those with pathogenic mutations were significantly younger, but did not significantly differ in the classic NPH pathologic findings, such as tubular cysts. On the other hand, the number of tubules with thick TBM duplication, which was defined as >10-μm thickness, was significantly higher in patients with genetically proven adult NPH than in those without pathogenic mutations. α-Smooth muscle actin (α-SMA)-positive myofibroblasts were detected inside thick TBM duplication.
The authors concluded that in adult patients with NPH, thick TBM duplication was the specific finding. Their analysis also suggested that older patients tended to have no pathogenic mutations, even when they were suspected to have NPH by renal biopsy. These findings could be the novel clinical clue for the diagnosis of NPH in adult patients. The study was published originally on March 3, 2021 in the journal Kidney International Reports.
Related Links:
Tokyo Medical and Dental University
Hamamatsu Photonics
Hitachi
Latest Pathology News
- Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
- Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
- Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
- Advances in Monkeypox Virus Diagnostics to Improve Management of Future Outbreaks
- Nanoneedle-Studded Patch Could Eliminate Painful and Invasive Biopsies
- AI Cancer Classification Tool to Drive Targeted Treatments
- AI-Powered Imaging Enables Faster Lung Disease Treatment
- New Laboratory Method Speeds Diagnosis of Rare Genetic Disease
- New Technology Autonomously Detects AI Hallucinations in Digital Pathology
- Novel Algorithm Rapidly Identifies Cell Types to Improve Cancer Diagnosis
- AI Method Speeds Up Cancer Tracking Using Blood Tests
- New AI Tool Improves Blood Cancer Diagnosis
- Novel Platform Technology Predicts Diseases by Early Detection of Aging Signals in Liver Tissue
- AI Model Detects More Than 170 Cancer Types
- Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer
- Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
New Blood Test for Leukemia Risk Detection Could Replace Bone Marrow Sampling
Myelodysplastic syndrome (MDS) is a condition typically associated with aging, where blood stem cells fail to develop into fully functional blood cells. Early and accurate diagnosis is vital, as MDS can... Read more
Blood Test Detects Preeclampsia Risk Months Before Symptoms Appear
Preeclampsia, a pregnancy-related complication characterized by elevated blood pressure and organ dysfunction, remains a major contributor to maternal and infant health issues globally. Existing screening... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more
Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more
Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more
POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more